Abstract Details
|
PRESENTER |
No disclosure on file |
| Amilton A. Barreira, MD (School of Medicine of Ribeirao Preto, University of Sao Paulo) | No disclosure on file |
| Mario Emilio Dourado Junior, Jr. (Bayer S.A - BHC) | No disclosure on file |
| Acary S. Oliveira, MD (UNIFESP - Escuela Paulista De Medicina) | No disclosure on file |
| Wilson Marques, Jr., MD (School of Medicine of Ribeirao Preto) | Dr. Marques has nothing to disclose. |
| Eric Klawiter, MD, FAAN (Massachusetts General Hospital) | Dr. Klawiter has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Galen/Atlantica. Dr. Klawiter has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Klawiter has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Banner Life Sciences. Dr. Klawiter has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Greenwich Biosciences. Dr. Klawiter has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for OM1. Dr. Klawiter has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG Therapeutics. The institution of Dr. Klawiter has received research support from Biogen. The institution of Dr. Klawiter has received research support from Abbvie. The institution of Dr. Klawiter has received research support from Genentech. |